Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Gross Profit | 9,140 | 10,690 | 13,820 | 12,460 | 16,630 |
| Operating Expenses | 3,340 | 3,410 | 4,110 | 3,350 | 3,450 |
| Operating Income | -3,340 | -3,410 | -4,110 | -3,350 | -3,450 |
| Pre-tax Income | -3,340 | -3,410 | -4,110 | -3,350 | -3,450 |
| Net Income Continuous | -3,340 | -3,410 | -4,110 | -3,350 | -3,450 |
| Net Income | $-3,340 | $-3,410 | $-4,110 | $-3,350 | $-3,450 |
| EBITDA(a) | $-1,060 | $-1,730 | $-2,170 | $-970 | $-360 |